“ambr15 for cell culture process optimization” Webinar 3P Biopharmaceuticals and Sartorius Stedim Biotech

Did you miss our webinar about our experience using ambr® 15 with CHO-S cell line for the production of monoclonal antibodies?

High-throughput media and feed screening for cell culture process optimization with multi-parallel micro bioreactors

In the development and delivery of high quality therapeutic proteins, high throughput process development tools can really accelerate early process understanding. ambr® 15 cell culture system offers an alternative approach to shake flask or conventional benchtop bioreactors in an automated, multi-parallel, high throughput format. The system can be implemented within the Upstream process workflow to generate early process development data at the small scale with very low demands on operator time, set-up and turn around due to automation and single-use components, and improve global costs of development due to the minimum scale the equipment is designed to operate. In this webinar Dr Marta Ruiz Guillén, USP development expert at 3P Biopharmaceuticals, and Javier Lobo, Field Marketing Manager for Sartorius Stedim Biotech in Latin America, Spain & Portugal; discuss the methods and results from performing media and feed screening evaluations in ambr® 15 with CHO-S cell line producing monoclonal antibodies and demonstrate the effectiveness of ambr 15 for rapid and robust cell culture process development. Watch it now and learn more about the experiments performed:

  • Screening of different media
  • Evaluation of different feeds
  • Effect of supplements
  • Optimization of feed strategy

Our dedicated team of specialists will be happy to discuss any of your Biopharmaceutical Manufacturing needs. Contact us on +34 948 346 480 or email withinus@3pbio.com

Related Content

Biovian and 3P Biopharmaceuticals join forces to create 3PBIOVIAN, a leading pan-European biologics CDMO

Published: 1st February 2024
Biovian and 3P Biopharmaceuticals (“3P”), two leading biologics Contract Development and Manufacturing Organizations (CDMOs), announced today their combination to establish a new pan-European leader in their field.
Read more

3P Biopharmaceuticals: building a legacy of innovation and excellence in biotechnology

Published: 20th December 2023
At the International Congress of High Impact Entrepreneurship, orchestrated by the European Business and Innovation Center of Navarra (CEIN), 3P Biopharmaceuticals (3P) emerges as the winner of the "Best Track Record in the CEIN incubators" award
Read more

3P Biopharmaceuticals and the University of Navarra bring the Neanderthal world and biomedicine to the public in a successful event.

Published: 19th October 2023
This afternoon Pamplona became the epicentre of knowledge and innovation in the field of biomedicine, thanks to the event "Exploring our shared legacy between Neanderthals and Sapiens: challenges and uncertainties of future biomedicine", organized by 3P Biopharmaceuticals in collaboration with the Faculty of Pharmacy and Nutrition of the University of Navarra.
Read more

Get in touch

Let’s discuss your biologics journey.

Discover more about our people, our passion, and how we can work together to improve lives.